SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories - Quaterly Results

11 Feb 2026 Evaluate
The revenue for the December 2025 quarter is pegged at Rs. 4575.72 millions, about 13.47% up against Rs. 4032.55 millions recorded during the year-ago period.Net profit showed a marginal rise at Rs. 234.96 millions for the quarter ended December 2025, as compared to corresponding quarter of last year.Operating profit surged to 458.23 millions from the corresponding previous quarter of 364.52 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 4575.72 4032.55 13.47 12183.82 11725.98 3.90 15545.35 15375.94 1.10
Other Income 39.33 48.74 -19.31 126.78 125.77 0.80 157.20 125.66 25.10
PBIDT 458.23 364.52 25.71 1014.43 1358.30 -25.32 1691.31 1743.84 -3.01
Interest 43.07 12.66 240.21 122.25 33.60 263.84 71.03 35.09 102.42
PBDT 415.16 351.86 17.99 903.14 1324.70 -31.82 1620.28 1708.75 -5.18
Depreciation 100.94 48.08 109.94 286.75 121.88 135.27 244.42 219.00 11.61
PBT 314.22 303.78 3.44 616.39 1202.82 -48.75 1375.86 1489.75 -7.64
TAX 79.26 76.91 3.06 157.05 306.17 -48.70 360.10 380.40 -5.34
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 47.27 -4.36 -1184.17
PAT 234.96 226.87 3.57 459.34 896.65 -48.77 1015.76 1109.35 -8.44
Equity 1095.84 1095.84 0.00 1095.84 1095.84 0.00 1095.84 1022.27 7.20
PBIDTM(%) 10.01 9.04 10.79 8.33 11.58 -28.12 10.88 11.34 -4.07

Morepen Laboratories Share Price

40.18 0.60 (1.52%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×